Diagnosis, Diagnostics, Immunodiagnosis & Immunodiagnostics:

9667.   Chincholkar SV, Kulkarni AT. Problems and prospects of dengue haemorrhagic fever. Indian med Gaz 2003; 137(2): 56-8.

9668.   Koraka P, Murgue B, Deparis X, Van Gorp EC, Setiati TE, Osterhaus AD, Groen J.  Elevation of soluble VCAM-1 plasma levels in children with acute dengue virus infection of varying severity. J Med Virol. 2004 Mar;72(3):445-50.

9669.   Mangada MM, Ennis FA, Rothman AL. Quantitation of dengue virus specific CD4+ T cells by intracellular cytokine staining. J Immunol Methods. 2004 Jan;284(1-2):89-97.

9670.   Wong SJ, Demarest VL, Boyle RH, Wang T, Ledizet M, Kar K, Kramer LD, Fikrig E, Koski RA. Detection of human anti-flavivirus antibodies with a west nile virus recombinant antigen microsphere immunoassay. J Clin Microbiol. 2004 Jan;42(1):65-72.

Pathogenesis:

9671.   Huber K, Loan LL, Chantha N, Failloux AB. Human transportation influences Aedes aegypti gene flow in Southeast Asia. Acta Trop. 2004 Mar;90(1):23-9.

9672.  Lin YS, Lin CF, Lei HY, Liu HS, Yeh TM, Chen SH, Liu CC. Antibody-mediated endothelial cell damage via nitric oxide. Curr Pharm Des. 2004;10(2):213-21. Review.

9673.  Mantke OD, Lemmer K, Biel SS, Groen J, Schmitz H, Durand JP, Zeller H, Niedrig M. Quality control assessment for the serological diagnosis of dengue virus infections. J Clin Virol. 2004 Feb;29(2):105-12.

9674.  Peyerl-Hoffmann G, Schwobel B, Jordan S, Vamisaveth V, Phetsouvanh R, Christophel EM, Phompida S, Sonnenburg FV, Jelinek T. Serological investigation of the prevalence of anti-dengue IgM and IgG antibodies in Attapeu Province, South Laos. Clin Microbiol Infect. 2004 Feb;10(2):181-4.

9675.   Shresta S, Kyle JL, Snider HM, Basavapatna M, Beatty PR, Harris E. Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical. J Virol. 2004 Mar;78(6):2701-10.

9676.  Thongtan T, Panyim S, Smith DR. Apoptosis in dengue virus infected liver cell lines HepG2 and Hep3B. J Med Virol. 2004 Mar;72(3):436-44.

Vaccines:

9677.   Deen JL. Editorial: the challenge of dengue vaccine development and introduction. Trop Med Int Health. 2004 Jan;9(1):1-3.

9678.   Sabchareon A, Lang J, Chanthavanich P, Yoksan S, Forrat R, Attanath P, Sirivichayakul C, Pengsaa K, Pojjaroen-Anant C, Chambonneau L, Saluzzo JF, Bhamarapravati N.   Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children. Pediatr Infect Dis J. 2004 Feb;23(2):99-109.

Therapy:

9679.   Alam R, Siddiqui FM, Rahman S, Haque AK, Sarker CB, Siddiqui NI, Das SN, Kahhar A, Zafar SA, Khandaker AK, Ahmed T, Haque MF. Management of dengue by the WHO guided national guidelines. Mymensingh Med J. 2004 Jan;13(1):43-7.